JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Epizyme (EPZM) Plans to Sell 4.29M Common in IPO
-
JMP Securities Downgrades Micron Technology (MU) to Market Perform
-
Notable 52-Week Highs and Lows of the Day 05/09: (GMCR) (TSLA) (MGM) High; (RAX) (LPSN) (GSS) Low
-
Notable Analyst Rating Changes 05/09: (CTRP) (MGM) (AWK) Upgraded; (RAX) (OFIX) (CLNE) Downgraded
-
Ellington Financial (EFC) Prices 5M Common Stock Offering
-
JMP Securities Starts Alexander & Baldwin (ALEX) at Market Outperform
-
JMP Securities Downgrades Transcept Pharmaceuticals (TSPT) to Market Perform
-
JMP Securities Downgrades Orthofix International (OFIX) to Market Perform
-
JMP Securities Starts Rally Software Development (RALY) at Market Outperform
-
JMP Securities Downgrades International Rectifier (IRF) to Market Perform
-
JMP Securities Starts Howard Hughes Corp (HHC) at Market Outperform
-
Notable 52-Week Highs and Lows of the Day 05/03: (AIG) (STX) (GILD) High; (DCTH) (ZAGG) (VCRA) Low
-
Notable Analyst Rating Changes 05/03: (GM) (BZH) (RDC) Upgraded; (DCTH) (SYY) (LULU) Downgraded
-
LTC Properties (LTC) Prices Upsized 3.5M Common Stock Offering
-
JMP Securities Upgrades Volcano Corp. (VOLC) to Market Perform
-
UPDATE: JMP Securities Downgrades Delcath Systems (DCTH) to Market Perform
-
JMP Securities Upgrades Beazer Homes (BZH) to Market Perform
-
Insys Therapeutics (INSY) IPO Prices at $8, Low End of Range
-
JMP Securities Upgrades Regeneron Pharma (REGN) to Market Outperform
-
Ellington Residential Mortgage REIT (EARN) IPO Opens, Trades Lower
-
JMP Securities Starts NICE Systems Ltd (NICE) at Market Outperform
-
JMP Securities Starts RenaissanceRe Holdings (RNR) at Market Outperform
-
Altisource (RESI) Announces 10M Common Stock Offering
-
JMP Securities Downgrades Employers Holdings (EIG) to Market Perform
-
Fifth Street Finance (FSC) Closes 13.5M Common Offering
-
Notable Analyst Rating Changes 04/15: (JCP) (CMG) (UA) Upgraded; (UNTK) (ABX) (PAAS) Downgraded
-
JMP Securities Starts Tetraphase Pharmaceuticals (TTPH) at Market Outperform
-
Rally Software (RALY) Software IPO Surges Higher
-
Durata Therapeutics (DRTX) Prices 7.15M Shares at $7
-
Notable Analyst Rating Changes 04/11: (LMT) (LRCX) (ADBE) Upgraded; (MSFT) (FTNT) (BRCM) Downgraded
-
Fifth Street (FSC) Prices 13.5M Offering at $10.85/Share
-
JMP Securities Starts Sourcefire (FIRE) at Market Perform
-
BioCryst Pharma (BCRX) Rally Overdone, Says Analyst
-
JMP Securities Starts Hyperion Therapeutics (HPTX) at Market Outperform
-
Textura Corp. (TXTR) Files $50M IPO
-
JMP Securities Starts Synta Pharma. (SNTA) at Market Perform
-
JMP Securities Starts Spectrum Pharmaceuticals (SPPI) at Market Perform
-
JMP Securities Starts OvaScience, Inc. (OVSC) at Market Outperform
-
JMP Securities Starts Mast Therapeutics (MSTX) at Market Outperform
-
JMP Securities Starts AVEO Pharmaceuticals (AVEO) at Market Perform
-
JMP Securities Starts Infinity Pharmaceutical (INFI) at Market Perform
-
JMP Securities Starts Astex Pharmaceuticals (ASTX) at Market Outperform
-
JMP Securities Starts Agenus Inc. (AGEN) at Market Outperform
-
UPDATE: JMP Securities Downgrades Intel (INTC) on Haswell Concerns; Intel Responds
-
Notable Analyst Rating Changes 04/01: (CWH) (NWSA) (EBAY) Upgraded; (INTC) (VCI) (YHOO) Downgraded
-
Notable Analyst Rating Changes 03/28: (RYAAY) (SM) (EXP) Upgraded; (EXA) (AEIS) (SNX) Downgraded
-
JMP Securities Starts Biogen (BIIB) at Market Outperform
-
JMP Securities Starts Jazz Pharmaceuticals (JAZZ) at Market Outperform
-
JMP Securities Starts Regeneron Pharma (REGN) at Market Perform
-
JMP Securities Starts Sangamo BioSciences (SGMO) at Market Outperform

